Identifying Emerging and Future Risks in Remote Health Monitoring and Treatment

Identifying Emerging and Future Risks in Remote Health Monitoring and TreatmentSince 2007, ENISA has been conducting a series of activities towards developing a comprehensive framework for identifying and assessing emerging and future risks (EFR). As a result of these activities, ENISA has constructed an EFR Framework. The EFR Framework is scenario-based and consists of certain phases for the formulation and analysis of scenarios, mobilisation of the necessary expertise (human resources) to assess and analyse the scenarios and leveraging of the management capabilities to collect and disseminate assessed information (e.g., scenario descriptions, threats, vulnerabilities, assets, impacts, risks, etc.).

The agency also sought to validate a European capacity for the evaluation of those risks to network and information security that may emerge in the near term, i.e. over the next three years. The work in this area is relatively new and, as such, calls for the interaction and co-operation of many leading experts from different disciplines, which is why ENISA established an EFR Stakeholder Forum and consulted with other subject matter experts. The EFR Stakeholder Forum, comprising partners and experts from industry, EU organisations and Member States, supports the agency in its deliberations on and assessment of EFRs and has contributed significantly to this pilot.

The pilot was undertaken in order to test and provide a "proof-of-concept" of the developed and proposed EFR Framework. It is based on a scenario in the area of remote health monitoring and treatment, an area which was selected after discussions with the EFR Stakeholder Forum. This report presents the results of the pilot exercise.

Download "Being diabetic in 2011" Identifying Emerging and Future Risks in Remote Health Monitoring and Treatment (.pdf 958 KB).

Download from the eHealthNews.EU Portal's mirror: "Being diabetic in 2011" Identifying Emerging and Future Risks in Remote Health Monitoring and Treatment (.pdf 958 KB).

For further information, please visit:
http://enisa.europa.eu

Most Popular Now

AI Predictions for Colorectal Cancer: On…

Colorectal cancer (CRC) ranks second in leading causes of cancer-related deaths globally, according to the WHO. For the first time, researchers from Helmholtz Munich and the University of Technology Dresden...

Combining AI Models Improves Breast Canc…

Combining artificial intelligence (AI) systems for short- and long-term breast cancer risk results in an improved cancer risk assessment, according to a study published in Radiology, a journal of the...

ChatGPT Shows 'Impressive' Acc…

A new study led by investigators from Mass General Brigham has found that ChatGPT was about 72 percent accurate in overall clinical decision making, from coming up with possible diagnoses...

Healthcare Chatbot: Expand Support with …

The Danish eHealth platform, sundhed.dk, has faced a substantial surge in requests from Danish citizens and has swiftly expanded its support and effectively adapt to the ongoing changes in queries due...

WiFi SPARK's Healthcare Business Re…

Leading WiFi provider WiFi SPARK is rebranding its healthcare arm as SPARK Technology Services Limited. The new identity marks the completion of the integration of the former Hospedia bedside unit...

ChatGPT is Debunking Myths on Social Med…

ChatGPT could help to increase vaccine uptake by debunking myths around jab safety, say the authors of a study published in the peer-reviewed journal Human Vaccines and Immunotherapeutics. The researchers asked...

Online AI-Based Test for Parkinson'…

An artificial intelligence (AI) tool developed by researchers at the University of Rochester can help people with Parkinson's disease remotely assess the severity of their symptoms within minutes. A study...

AI Performs Comparably to Human Readers …

Using a standardized assessment, researchers in the UK compared the performance of a commercially available artificial intelligence (AI) algorithm with human readers of screening mammograms. Results of their findings were...

Siemens Healthineers Expands Production …

Siemens Healthineers is expanding its site in Rudolstadt, Germany. By mid 2024, a new manufacturing building will be built on the site. The new manufacturing plant will produce electron accelerators...

More Cases of Breast Cancer Detected wit…

One radiologist supported by AI detected more cases of breast cancer in screening mammography than two radiologists working together, reports the ScreenTrustCAD study from Karolinska Institutet in The Lancet Digital...

MEDICA 2023 + COMPAMED 2023: "Where…

13 - 16 November 2023, Düsseldorf, Germany. The medical technology market is in worldwide motion and the signs ahead of MEDICA 2023 and COMPAMED 2023 in Düsseldorf as the internationally leading...

Smartphone Technology Expected to Advanc…

Since the 1980s, we have known that neurological soft signs (NSS) can distinguish people with schizophrenia from psychiatrically healthy individuals. NSS are subtle neurological impairments that principally manifest as decreased...